Advanced Materials Development-How Do We Define Success?
نویسندگان
چکیده
منابع مشابه
How do we define "difficult" patients?
Why do our patients have to meet our needs? The image I have is not someone who is difficult, but rather someone who is doing the best she can in her own life and is not willing to bend to fit our expectations. R eceiving a referral for a patient who is described as being difficult is not uncommon for me, particularly after many years of working in what some might call “non-mainstream” areas. H...
متن کاملHow Do We Define Cure of Diabetes?
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or ...
متن کاملHow should we define health?
Machteld Huber senior researcher, J André Knottnerus president, Scientific Council for Government Policy , Lawrence Green editor in chief, Oxford Bibliographies Online—public health , Henriëtte van der Horst head , Alejandro R Jadad professor , Daan Kromhout vice president, Health Council of the Netherlands , Brian Leonard professor , Kate Lorig professor , Maria Isabel Loureiro coordinator for...
متن کاملEditorial Commentary: Pseudomonas aeruginosa Eradication: How Do We Measure Success?
Lung disease remains the major cause of morbidity and mortality for people living with cystic fibrosis (CF) [1]. Dysfunctional chloride conductance in the airways results in impaired mucus clearance, which drives a vicious cycle of infection, inflammation, and airway destruction. Pseudomonas aeruginosa (Pa) is a bacterial pathogen largely feared by the CF community as its chronic presence is as...
متن کاملHow to Define Treatment Success and Failure*
Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis for HIVinfected patients in the last 5 years, as demonstrated by several studies, including the EuroSIDA study—in which patients’ CD4 cell counts of <20 cells/mL improved to 20 to 49 cells/mL and the projected 25% mortality rate over the following year was reduced to <10, and a collaborative effort among 8 Euro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: MRS Bulletin
سال: 1993
ISSN: 0883-7694,1938-1425
DOI: 10.1557/s0883769400038987